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Abstract Endogenous endophthalmitis is a rare and
severe intraocular infection which can be vision-
threatening. We describe a case of bilateral fungal
endogenous endophthalmitis in a 64-year-old male
which was successfully treated with systemic admin-
istration of fluconazole followed by pars plana vitrec-
tomy with an intravitreous injection of amphotericin B.
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Introduction
Endogenous endophthalmitis is a severe infrequent
disease which can lead to loss of vision.
We describe a case of bilateral fungal endogenous
endophthalmitis in a 64-year-old male which was
successfully treated with intravenous and oral fluco-
nazole followed by pars plana vitrectomy and an
intravitreous injection of amphotericin B.
Case report
A 64-year-old Caucasian male was referred to the
Department of Ophthalmology, Medical University of
Lodz (Poland) to undergo planned consultation for
decreased vision.
The patient had been treated in the Department of
General and Transplantation Surgery where he under-
went a pancreatoduodenectomy (by Whipple) as
treatment for carcinoma of the distal part of the bile
duct and a right-sided hemicolectomy as a treatment of
complications which developed after the first surgery.
After these operations, the patient received long-
standing intravenous feeding and intensive general
antibiotic therapy, which was based on bacterial
cultures and antibiogram. The patient’s general con-
dition was considered serious at that time. Three
weeks after the first operation, the patient noticed
bilateral deterioration of vision with ‘spider net’
floaters and ocular pain.
During the first ophthalmic examination his best-
corrected visual acuity (BCVA) was 0.02 in both eyes,
and intraocular pressure (IOP) was 12 mm Hg. Slit-
lamp examination revealed bilateral ciliary engorge-
ment and posterior synechiae. In the eye fundus
examination, convex, whitish, well-defined inflamma-
tory lesions of 0.5 mm diameter were present on the
retina (multifocal retinitis) and inflammatory exudates
were present in the vitreous. Juxtafoveal lesions were
seen in both eyes—in the right eye three of these
lesions were present on the edge of the macula and in
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the left eye one lesion was present in the upper part of
the macula (Fig. 1). Bilateral endogenous endophthal-
mitis was diagnosed. As the clinical appearance
suggested fungal etiology, the patient was offered an
intravitreous injection of amphotericin B but did not
agree to undergo this treatment. At this point the
patient also refused to undergo pars plana vitrectomy.
Intravenous fluconazole 200 mg/day was adminis-
tered, as well as topical treatment with 1 % tropica-
mide eyedrops.
After treatment, the symptoms of anterior uveitis
resolved within 2 days. Fungal culture from a blood
sample was performed three times with negative
results each time.
During the following week a further decrease of
visual acuity was observed (BCVA of 0.01 in both
eyes). In the vitreous the exudates were thicker and
there were numerous ‘cotton ball’ colonies present.
There were numerous small round whitish spots
located along the larger retinal vessels.
A few days later the patient’s general condition and
ophthalmic condition both improved. Retinal lesions
started to decrease in size and became flatter and paler.
At the same time visual acuity improved to 0.1 in both
eyes, and a week later it improved to 0.2. Nevertheless,
the vitreous exudate became thicker and more
condensed (Figs. 2, 3). In the next few days, posterior
vitreous detachment developed and visual acuity
decreased to 0.02 in both eyes.
The patient was discharged from the Department of
General Surgery and was admitted to the Department of
Ophthalmology where he underwent pars plana vitrec-
tomy with an intravitreous injection of amphotericin B
in both eyes. This treatment resulted in a marked
increase in visual acuity (BCVA in the right and left eye
was 0.5 and 0.3, respectively). Vitreous tap was taken
during vitrectomy and samples of vitreous fluid were
sent for cultures (bacteriologic and mycological) and
direct specimens were made. The culture results were
negative; however, direct specimens revealed the
presence of Candida sp. The patient received fluconaz-
ole intravenously and orally for a total of 3 months.
After the active inflammatory reaction was con-
trolled pharmacologically, retinal and choroidal scars
were present in both eyes. In the left eye one of these
scars was located in the upper part of the macula.
One year after the initial diagnosis of endophthal-
mitis, the patient’s visual acuity amounted to BCVA
of 0.4 in the right eye and 0.1 in the left eye. Mild
nuclear cataracts have recently been found in both
eyes.
Discussion
Endogenous endophthalmitis is a rare and severe
intraocular infection which can be vision-threatening
and results in total loss of vision [1]. It is usually a
result of hematogenous dissemination of pathogens
from another site of coexisting infection.
Fungi are the most commonly encountered micro-
organisms that cause endogenous endophthalmitis. C.
albicans is the most frequent pathogen, accounting for
approximately 75–80 % of fungal infections [1, 2].
Candida fungi are commensal organisms, which can
cause infections in the immunosuppressed [3].
Fig. 1 Early manifestation of fungal endophthalmitis. Multifocal retinitis is visible, as well as inflammatory exudates in the vitreous
(OD, the right eye; OS, the left eye)
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There are many risk factors connected to endoge-
nous endophthalmitis, the most important being
intravenous antibiotic treatment, major surgery, intra-
venous catheters, intravenous infusions, steroid treat-
ment, therapy with immunosuppresive agents and
intravenous drug abuse [1]. Fungal dissemination is
particularly frequent in diabetic patients, neonates,
and burn patients [3]. It may lead to endocarditis,
meningitis, arthritis, choroiditis, retinitis or endoph-
thalmitis [3].
Patients after gastrointestinal tract surgery tend to
have compromised circulation in the involved tissues
and often undergo intravenous broad-spectrum anti-
biotic treatment afterwards, which may be a predis-
posing factor to Candida infiltration [1]. Our patient
had undergone major gastroinestinal tract surgery,
Fig. 2 a, b Bilateral endogenous fungal endophthalmitis one week later (OD, the right eye; OS, the left eye)
Fig. 3 Consecutive ultrasound scans, showing gradual thickening of vitreous exudate and posterior vitreous detachment (a–c) and
clear vitreous chamber after pars plana vitrectomy (d)
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which led to prolonged intravenous broad-spectrum
antibiotic treatment combined with prolonged intra-
venous feeding, which in turn caused endogenous
fungemia.
The main result of ocular candidiasis is a chorioret-
initis; however, the infection can spread to the optic
nerve, vitreous, and ciliary body and cause endophthal-
mitis or panophthalmitis. It is estimated that in approx-
imately 67 % of patients the disease is bilateral and in
about 80 % of patients the lesions are multifocal [2, 4].
Patients may experience changes in visual acuity,
scotomas, floaters, photophobia or pain. In most
patients, macular or vitreous lesions are present,
which are usually described as round and whitish,
small, focal, perivascular, chorioretinal lesions with
surrounding vitreous inflammation (vitritis). They are
also referred to as white fluffy exudates with well-
circumscribed borders. Vascular sheathing, Roth’s
spots, and exudative retinal detachment may also be
present. In addition, anterior segment inflammation
(anterior uveitis) may develop [1, 2].
Usually, the diagnosis is based on history and
clinical findings; however, it should be confirmed by
isolating the microorganism from infected tissues
(blood, aqueous fluid or vitreous) [2].
The prognosis for endogenous endophthalmitis is
usually poor, which results from the fact that patients
are frequently immunocompromised, the microorgan-
ism is virulent and diagnosis is often delayed [1, 2].
Endogenous endophthalmitis responds better to
intravenous antibiotics than exogenous endophthal-
mitis. It is important to make a diagnosis as early as
possible and to start appropriate treatment immedi-
ately. It is therefore crucial to identify the causative
agent correctly. Blood or aqueous humor cultures and
determining the susceptibility of the microorganisms
to various antifungal drugs help to choose the most
effective treatment [1].
In the described case, fungal culture from a blood
sample was performed three times and was negative
on each occasion, so the initial diagnosis was based on
the clinical picture. Later in the course of the disease
direct specimens from the vitreous tap confirmed the
presence of Candida sp. Another useful diagnostic
option for detecting the DNA of Candida species is
broad-range real-time polymerase chain reaction;
however, this method was unavailable to us [5].
In our patient, juxtafoveal lesions were seen in both
eyes as well as vitritis, which implies poor final visual
prognosis and is an indication for intravitreous injec-
tion or vitrectomy. As the patient at first refused an
intravitreous injection of amphotericin B and pars
plana vitrectomy, only intravenous fluconazole was
started. Pars plana vitrectomy was finally performed
about a week after the patient’s initial visit, which
might have influenced the final visual acuity.
In ocular candidiasis it is advised that treatment
should be commenced as quickly as possible; how-
ever, there are studies showing that, even when the
treatment is commenced on time, final visual acuity is
poor [6]. This is often a result of macular photorecep-
tor damage, which was also the case in our patient,
who was later found to have bilateral chorioretinal
scars in the macular area.
In a study by Sallam et al. [7], 55 % of eyes with
Candida endophthalmitis had visual loss (defined as
visual acuity of \20/40) and 32 % had severe visual
loss (defined as visual acuity of \20/200). Authors
concluded that Candida endophthalmitis was associ-
ated with a high rate of visual loss and they also found
that early vitrectomy reduced the risk of retinal
detachment significantly. Poor presenting visual acu-
ity and centrally located fungal lesions were found to
be the main factors associated with poor visual
outcome [7].
It is thought that early systemic treatment should be
used, either with imidazoles or amphotericin B [1, 8,
9]. In cases of progressive vitritis, vitrectomy should
be performed to remove the microorganisms and
intravitreal amphotericine B should be used in
conjunction with vitrectomy [2, 8, 9].
Our patient agreed to undergo pars plana vitrec-
tomy only when visual acuity dropped again after it
initially increased, as a result of the introduction of
intravenous fluconazole.
In the literature it is stressed that oral fluconazole
may be used as an alternative treatment to intravitreal
amphotericine B, and may be used after vitrectomy for
a prolonged period of time, especially in cases of
Candida endophthalmitis which are resistant to
amphotericin B [1, 8–10].
In our case, when the patient refused vitrectomy, we
decided to introduce systemic fluconazole, which was
continued for approximately 3 months after vitrec-
tomy with intravitreal amphotericine B administra-
tion. In the literature, there are reports stating that
bilateral endogenous Candida endophthalmitis can be
successfully treated with pars plana vitrectomy and
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intravenous fluconazole alone [11]. Some authors
advocate also using systemic corticosteroids in addi-
tion to amphotericin B; however, it is advised to start
steroids no sooner than 48 h after antifungal therapy
[2, 10].
The present case report demonstrates that intrave-
nous and oral fluconazole followed by pars plana
vitrectomy with an intravitreous injection of ampho-
tericin B, is an effective treatment for endogenous
fungal endophthalmitis. Direct specimens of the
vitreous tap material should be made, as they allow
identification of the causative pathogen even in cases
of negative culture results.
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